CDCA3 antibody (AA 201-268) (Cy7)
Quick Overview for CDCA3 antibody (AA 201-268) (Cy7) (ABIN889663)
Target
See all CDCA3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 201-268
-
Cross-Reactivity
- Rat
-
Predicted Reactivity
- Human,Mouse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDCA3
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CDCA3 (Cell Division Cycle Associated 3 (CDCA3))
-
Alternative Name
- CDCA3
-
Background
-
Synonyms: CDCA 3, Cell division cycle associated 3, Cell division cycle associated protein 3, Gene rich cluster C8, Gene rich cluster protein C8, GRCC 8, GRCC8, MGC2577, TOME 1, TOME1, Trigger of mitotic entry 1, C8 antibody, Trigger of mitotic entry protein 1, CDCA3_HUMAN .
Background: CDCA3 (Cell division cycle associated 3) is an F-box-like protein which is required for entry into mitosis. It is associated with SKP1 as part of a SCF (SKP1-cullin-F-box) protein ligase complex, and is required for the ubiquitination and degradation of the CDK1 inhibitory tyrosine kinase WEE1 at G2/M phase.
-
Gene ID
- 83461
Target
-